Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 2 Results

  1. 1

    Study of family planning contraceptive boxes supplied to depot holders.

    Sandhu SK; Sinha KS; Bhardwaj KS

    New Delhi, Central Family Planning Institute, October 1970. (CFPI Technical Paper No. 12) 12 p

    Following the complaint from the depot holders working in the project areas of the Central Family Planning Institute that they faced difficulty in keeping contraceptives which were supplied to them for distribution, 14 boxes were specially designed and distributed to 10 depot holders in urban areas and 4 depot holders in rural projects. All 14 depot holders stated that the box had helped in better storage of contraceptives; 11 depot holders reported that the box had provided opportunities for the public to locate the place of contraceptives; 12 boxes as observed by the interviewers were utilized for keeping contraceptives and family planning literature, while of the remaining 2, 1 was used for keeping biscuits and another was not visible.(AUTHORS', MODIFIED)
    Add to my documents.
  2. 2

    Epidemiological and public health aspects of oral contraceptives and thromboembolic disease.

    Vessey MP

    Journal of Clinical Pathology 23 (Suppl. 3):62-66. 1970. 1970; 23 Suppl(3):62-66.

    The evidence linking oral contraceptive use with venous thrombosis pulmonary embolism and cerebral thrombosis and the risks associated with pill use are reviewed. 3 British and 1 American case-controlled retrospective studies yielded 3-fold risk for superficial thrombophlebitis, 4-7 fold risk for hospitalization or 5-8 fold risk for death from deep thrombosis, cerebral thrombosis or pulmonary embolism among pill users relative to nonusers. The proportion of users increased with certainty of diagnosis, frequency of pill use among population in Britain, and among sequential pill users in U.S. This association of thromboembolic disease with pill use is also consistent with results of several reviews of clinical series, 2 analyses of trends in mortality statistics, reports of thromboembolism in those given estrogen to suppress lactation, and for treatment of prostate cancer. Biomedical research on clotting factors, platelet behavior and blood vessels also implicates estrogen. Absolute risks of death from thromboembolism due to pills from British mortality statistics are about one-fourth the risk of death from motor accidents, and one-twentieth the risk of death from all causes of pregnancy. Thus the pill is probably as safe as barrier methods, considering their failure rates, and possibly more risky than the IUD.
    Add to my documents.